ArticleScientific reports2025
Transformer-inspired training principles based breast cancer prediction: combining EfficientNetB0 and ResNet50.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- An Attention-Residual Hybrid CNN for CT-Based Multiclass Classification of Alcohol-Related Liver Disease: Differential Diagnosis Against HBV-Related Cirrhosis.Diagnostics (Basel, Switzerland) · 2026Article
- Interpretable CRAM‑Enhanced Lightweight Dual‑Branch CNN for Real‑Time Breast Cancer Histopathology in Internet‑of‑Medical‑Things Environments.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- A deep learning framework for breast cancer diagnosis using Swin Transformer and Dual-Attention Multi-scale Fusion Network.Scientific reports · 2026Article
- Advances in AI-based diagnosis of Alzheimer's disease using MRI: a comprehensive survey.Frontiers in medicine · 2026Review
- Assessment of transformer-based AI in clinical oncology.BMC medical informatics and decision making · 2025Article
- Deep‑learning based osteoporosis classification in knee X‑rays using transfer‑learning approach.Scientific reports · 2025Article
- Optimizing YOLOv11 for automated classification of breast cancer in medical images.Scientific reports · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a leading killer and has been deepened by COVID-19, which affected diagnosis and treatment services. The absence of a rapid, efficient, accurate diagnostic tool remains a pressing issue for this severe disease. Thus, it is still possible to encounter issues concerning diagnostic accuracy and utilization of errors in the sphere of machine learning, deep learning, and transfer learning models. This paper presents a new model combining EfficientNetB0 and ResNet50 to improve the classification of breast histopathology images into IDC and non-IDC classes. The implementation steps, it include resizing all the images to be of a standard size of 128*128 pixels and then performing normalization to enhance the learning model. EfficientNetB0 is selected for its efficient yet effective performance while ResNet50 employs deep residual connections to overcome the vanishing gradient problem. The proposed model that incorporates some of the characteristics from both architectures turns out to be very resilient and accurate in classification. The model demonstrates superior performance with an accuracy of 94%, a Mean Absolute Error (MAE) of 0.0628, and a Matthews Correlation Coefficient (MCC) of 0.8690. These results outperform previous baselines and show that the model performs well in achieving a good trade-off between precision and recall. The comparison with the related works demonstrates the superiority of the proposed ensemble approach in terms of accuracy and complexity, which makes it efficient for practical breast cancer diagnosis and screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.